Related Experiment Video
Updated: May 6, 2026

07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
8.4K
A 39-year-old woman with hypercholesterolemia
1Harvard Medical School, Boston, Mass, USA. mmittlem@bidmc.harvard.edu
JAMA
|July 20, 2006
Summary
This case study examines a 39-year-old African American woman with high cholesterol and a family history of stroke. It discusses her coronary heart disease (CHD) risk and lipid-lowering therapy options.
Area of Science:
- Cardiology
- Preventive Medicine
- Pharmacology
Background:
- A 39-year-old African American woman presents with hypercholesterolemia (total cholesterol 277 mg/dL) and controlled hypertension.
- She has a concerning family history, including a brother who suffered a stroke in his 30s and a mother with breast cancer.
Observation:
- Her estimated 10-year risk for coronary heart disease (CHD) using the Framingham Risk Score is low (1-2%).
- However, this score may underestimate her actual risk due to her ethnicity and family history of premature CHD.
Findings:
- The case discusses the patient's concerns regarding dietary supplements versus cholesterol-lowering medications.
- It reviews the evidence for various lipid-lowering therapies and their long-term adherence implications.
Implications:
- Accurate cardiovascular risk assessment in young to middle-aged women requires consideration of factors beyond standard risk scores.
- Personalized management strategies, including pharmacotherapy and lifestyle modifications, are crucial for long-term cardiovascular health.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Lipids: Dietary Sources and Requirements
2.5K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.5K
Cholesterol: Significance and Regulation
2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.1K
Angina IV: Management
496
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
496
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747

